Allergy Asthma Respir Dis.
2014 Sep;2(4):314-314. 10.4168/aard.2014.2.4.314.
ERRATUM: Author's Name Correction. The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: A pilot study
- Affiliations
-
- 1Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
- 2Dong-A Pharm. Co. Ltd., Seoul, Korea.
- KMID: 2262404
- DOI: http://doi.org/10.4168/aard.2014.2.4.314
Abstract
- The fourth author's name was misprinted.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: A pilot study
- Effects of Recombinant Human Epidermal Growth Factor on the Proliferation and Radiation Survival of Human Fibroblast Cell Lines in Vitro
- A Study of Pilot-Efficacy
- An Experimental Study of the Effect of Acidic Fibroblast Growth Factor on Nerve Regeneration
- Pfeiffer Syndrome Type 2 with Sporadic Fibroblast Growth Factor Receptor 2 Mutation and Coccygeal Anomaly
